Gene discovery points towards non-hormonal male contraceptive
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
The finding could lead to alternatives to conventional male contraceptives that rely on disrupting the production of hormones, such as testosterone and can cause side-effects such as irritability, mood swings and acne.
Research, led by the University of Edinburgh, has shown how a gene Katnal1 is critical to enable sperm to mature in the testes.
If scientists can regulate the Katnal1 gene in the testes, they could prevent sperm from maturing completely, making them ineffective, without changing hormone levels.
The research, which is published in the journal PLoS Genetics, could also help in finding treatments for cases of male infertility, when malfunction of the Katnal1 gene hampers sperm development.
Dr Lee Smith, Reader in Genetic Endocrinology at the Medical Research Council Centre for Reproductive Health at the University of Edinburgh, said: "If we can find a way to target this gene in the testes, we could potentially develop a non-hormonal contraceptive.
"The important thing is that the effects of such a drug would be reversible because Katnal1 only affects sperm cells in the later stages of development, so it would not hinder the early stages of sperm production and the overall ability to produce sperm.
"Although other research is being carried out into non-hormonal male contraceptives, identification of a gene that controls sperm production in the way Katnal1 does is unique and a significant step forward in our understanding of testis biology."
Scientists funded by the Medical Research Council found that male mice, which were modified so they did not have the Katnal1 gene, were infertile.
Further investigation showed that this was because the gene was needed to allow the sperm to develop and mature.
The researchers showed that Katnal1 was needed to regulate a scaffolding structure, known as microtubules, which forms part of the cells that support and provide nutrients to developing sperm.
Break down and rebuilding of these microtubules, enable the sperm cells to move within the testes as they mature. Katnal1 acts as the essential controller of this process.
More information: Smith LB, Milne L, Nelson N, Eddie S, Brown P, et al. (2012) KATNAL1 Regulation of Sertoli Cell Microtubule Dynamics Is Essential for Spermiogenesis and Male Fertility. PLoS Genet 8(5): e1002697. doi:10.1371/journal.pgen.1002697
Journal reference:
PLoS Genetics
Provided by
University of Edinburgh
-
Genetic alteration linked with human male infertility
Sep 30, 2010 |
not rated yet |
0
-
Gene involved in sperm-to-egg binding is key to fertility in mammals
May 01, 2012 |
not rated yet |
0
-
Treating male infertility with stem cells
Mar 02, 2007 |
not rated yet |
0
-
Worm sperm gives clue to male infertility
Sep 05, 2006 |
not rated yet |
0
-
'The pill' for him: Scientists find a hormonal on-and-off switch for male fertility
Nov 30, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...
Genetics
May 20, 2013 |
5 / 5 (1) |
0
|
Researchers identify new circadian clock component
Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.
Genetics
May 16, 2013 |
3 / 5 (1) |
1
|
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Genetics
May 16, 2013 |
5 / 5 (1) |
3
|
Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing
In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...
Genetics
May 16, 2013 |
not rated yet |
0
Experts urge caution over use of new genetic sequencing techniques
The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...
Genetics
May 16, 2013 |
not rated yet |
0
Italy approves law on controversial stem cell therapy
Italian lawmakers on Wednesday gave their final approval to a law that allows limited use of a controversial type of stem cell therapy which has been condemned by many scientists but has given hope to families of terminally-ill ...
Beta-blockers may boost chemo effect in childhood cancer
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Jo ...
Japan hospital tests powerful breast cancer therapy
A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, non-surgical, short-term radiation therapy for breast cancer.
Mysterious illness kills two in southeast Alabama
(AP)—Alabama health officials say a mysterious respiratory illness has left five people hospitalized and two dead in the southeastern part of the state.
Targeting the X-factor to tackle cardiovascular disease
New research at The University of Nottingham aimed at preventing harmful blood clots associated with heart disease and stroke has recently received a major funding boost from the British Heart Foundation.
Study focuses on new mums' sleepiness and injury risk on the road
New mothers throughout Australia are needed to help QUT sleep researchers investigate whether the disrupted sleep experienced by mothers when caring for their new baby raises the risk of injury while driving.